T. Scocchia

  • Citations Per Year
Learn More
OBJECTIVE To determine the longterm safety and efficacy of etidronate therapy in patients in whom corticosteroid induced bone loss has already occurred. METHODS We performed a 36 month observational cohort study in which all data were obtained from Canadian Database of Osteoporosis and Osteopenia (CANDOO) patients. The etidronate group consisted of 24(More)
E~trogen deficiency due to menopause leads to progressive loss o f bone mass, vertebral deformities and fractures. Clodronate is an inhibitor o f bone resorption, developed a s an agent to fight hypercalcemia and bone lysis. The aim o f the study was tO evaluate the effect o f the treatment with clodronate on Ca-P-Mg homeostasis, bone mass and vertebral(More)
  • 1